San Francisco Agency has assisted Ironic Biotech with PR, helping them raise awareness about the fact that they successfully closed a pre-seed funding round of €1 million led by Nordic Foodtech VC. Ironic Biotech has discovered a new generation of plant-derived proteins that contain iron, which are highly bioavailable with no side effects. The Swedish company was founded in 2020 by Nélida Leiva Eriksson, who holds a PhD in protein design and molecular biology.
San Francisco Agency helped clarify the key messaging and PR assets for Ironic Biotech, while conducting a media landscape research and creating VIP media lists for the company before the final pitching was done.
The news about the fact that the Lund-based biotech startup Ironic Biotech successfully closed a pre-seed funding round of €1 million led by Nordic Foodtech VC gained widespread attention in both Nordic and International press.
San Francisco Agency's expertise in PR and social media propelled Ironic Biotech's visibility to new heights. Their guidance in navigating tier 1 media interviews was invaluable, ensuring our messaging reached a global audience effectively. Thanks to San Francisco Agency's strategic PR support, Ironic Biotech garnered significant attention from prospective clients, partners, and talent.